ATC code J04

ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup J04 is part of the anatomical group J Antiinfectives for systemic use.<ref>

ATC/DDD Index 2022

code J04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ04.<ref>

ATCvet Index 2022

code QJ04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J04A Drugs for treatment of tuberculosis

J04AA Aminosalicylic acid and derivatives

J04AA01 Aminosalicylic acid

J04AA02 Sodium aminosalicylate

J04AA03 Calcium aminosalicylate

J04AB Antibiotics

J04AB01 Cycloserine

J04AB02 Rifampicin

J04AB03 Rifamycin

J04AB04 Rifabutin

J04AB05 Rifapentin

J04AB30 Capreomycin

J04AC Hydrazides

J04AC01 Isoniazid

J04AC51 Isoniazid, combinations

J04AD Thiocarbamide derivatives

J04AD01 Protionamide

J04AD02 Tiocarlide

J04AD03 Ethionamide

J04AK Other drugs for treatment of tuberculosis

J04AK01 Pyrazinamide

J04AK02 Ethambutol

J04AK03 Terizidone

J04AK04 Morinamide

J04AK05 Bedaquiline

J04AK06 Delamanid

J04AK07 Amithiozone

J04AM Combinations of drugs for treatment of tuberculosis

J04AM01 Streptomycin and isoniazid

J04AM02 Rifampicin and isoniazid

J04AM03 Ethambutol and isoniazid

J04AM04 Thioacetazone and isoniazid

J04AM05 Rifampicin, pyrazinamide and isoniazid

J04AM06 Rifampicin, pyrazinamide, ethambutol and isoniazid

J04AM07 Rifampicin, ethambutol and isoniazid

J04AM08 Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine

J04B Drugs for treatment of lepra

J04BA Drugs for treatment of lepra

J04BA01 Clofazimine

J04BA02 Dapsone

J04BA03 Aldesulfone sodium